MDNA Life Sciences Statistics
Total Valuation
MDLS has a market cap or net worth of $51.95 million. The enterprise value is $67.68 million.
| Market Cap | 51.95M |
| Enterprise Value | 67.68M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
MDLS has 9.45 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 9.45M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.42 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -93.92% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $240,153 |
| Profits Per Employee | -$252,491 |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MDLS had revenue of $3.60 million and -$3.79 million in losses. Loss per share was -$0.40.
| Revenue | 3.60M |
| Gross Profit | 1.78M |
| Operating Income | -1.02M |
| Pretax Income | -3.79M |
| Net Income | -3.79M |
| EBITDA | -1.48M |
| EBIT | -2.12M |
| Loss Per Share | -$0.40 |
Balance Sheet
The company has $958,212 in cash and $16.69 million in debt, giving a net cash position of -$15.73 million or -$1.67 per share.
| Cash & Cash Equivalents | 958,212 |
| Total Debt | 16.69M |
| Net Cash | -15.73M |
| Net Cash Per Share | -$1.67 |
| Equity (Book Value) | -17.62M |
| Book Value Per Share | -1.87 |
| Working Capital | -18.37M |
Cash Flow
In the last 12 months, operating cash flow was -$557,417 and capital expenditures -$63,932, giving a free cash flow of -$621,349.
| Operating Cash Flow | -557,417 |
| Capital Expenditures | -63,932 |
| Free Cash Flow | -621,349 |
| FCF Per Share | -$0.07 |
Margins
Gross margin is 49.49%, with operating and profit margins of -28.29% and -105.14%.
| Gross Margin | 49.49% |
| Operating Margin | -28.29% |
| Pretax Margin | -105.14% |
| Profit Margin | -105.14% |
| EBITDA Margin | -41.11% |
| EBIT Margin | -58.86% |
| FCF Margin | -17.25% |
Dividends & Yields
MDLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -7.29% |
| FCF Yield | -1.20% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDLS has an Altman Z-Score of -26.35 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.35 |
| Piotroski F-Score | 1 |